₹105.00
+0.43%NSE close, 16 Nov 2026
−6.08%
NEOCHEM BIO SOLUTIONS is a small cap company, listed on NSE SME under the symbol NEOCHEM. At ₹105.00 a share, the market values the whole company at ₹180 crore. NSE SME is the exchange's platform for small and medium companies, which report their results every half year.
In FY26, it reported sales of ₹111 crore and a net profit of ₹12 crore, an operating margin of 17.9%.
The market values the company at 12.2 times its profit over the last twelve months and 2.07 times its book value; its return on equity is 17.0% and its borrowings are 0.38 times its equity.
Promoters hold 66.88% of the shares. Foreign institutions hold 0.18%, and domestic institutions, mutual funds among them, 12.46%.
Listed on NSE SME, the platform for small and medium companies: its shares trade in large lots and often thinly, so the price can move sharply on a few trades, and companies file results every half year.
₹ crore. Standalone figures: the company files no consolidated results.
| Line | 6M to Mar 2026 | 6M to Sep 2026 |
|---|---|---|
| Sales | 64.9 | 68.9 |
| Expenses | 53.6 | 56.9 |
| Operating profit | 11.3 | 12.0 |
| Operating margin | 17.4% | 17.5% |
| Other income | 1.4 | 0.4 |
| Interest | 1.5 | 1.3 |
| Depreciation | 0.6 | 0.7 |
| Profit before tax |
Transcript
Link of Recording
The Unaudited Half Yearly financial results for the period ended September 30, 2026.
| 9.9 |
| 10.5 |
| Tax | 3.0 | 2.6 |
|---|
| Net profit | 6.9 | 7.9 |
|---|
| EPS (₹) | 4.97 | 4.58 |
|---|
₹ crore, financial years to March.
| Line | FY26 |
|---|---|
| Sales | 111 |
| Expenses | 90.9 |
| Operating profit | 19.9 |
| Operating margin | 17.9% |
| Other income | 2.7 |
| Interest | 3.5 |
| Depreciation | 1.2 |
| Profit before tax | 17.2 |
| Tax | 5.2 |
| Net profit | 12.0 |
| EPS (₹) | 8.71 |
₹ crore, at each year's end and the latest half year.
₹ crore, by financial year, and the latest half year.
| Line | FY26 | 6M to Sep 2026 |
|---|---|---|
| From operations | −19.1 | −1.1 |
| From investing | −6.5 | −13.0 |
| From financing | 25.7 | 14.0 |
| Spent on fixed assets | −2.6 | −14.5 |
| Free cash flow | −21.6 | −15.5 |
Margins, returns, debt, tax and cash.
| Line | FY26 |
|---|---|
| Net margin | 10.9% |
| Operating margin | 17.9% |
| Return on equity | 15.3% |
| Return on capital employed | 21.4% |
| Return on assets | 10.3% |
| Debt to equity | 0.23 |
| Interest coverage | 5.90 |
| Debt to assets | 0.15 |
| Current ratio | 2.39 |
| Quick ratio | 1.58 |
| Cash ratio | 0.01 |
| Asset turnover | 0.95 |
| Fixed asset turnover | 5.56 |
| Inventory turnover | 2.60 |
| Receivables turnover | 2.30 |
| Gross margin | 32.5% |
| Cash from operations to profit | -158.0% |
| Effective tax rate | 30.0% |
Schedule of meet
Neochem Bio Solutions has submitted Statement of Investor Grievances under Reg. 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the quarter ended 30th September, 2026.
Has informed regarding Submission of the Compliance Report on Corporate Governance for the Quarter and half year ended on 30th September, 2026
SDD Certificate as per SEBI (Prohibition of Insider Trading) Regulations, 2015
Presentation
A copy Srutinizers report of Annual General Meeting held on September 21, 2026. Further, the company has informed the Exchange regarding voting results.
Proceedings of Annual General Meeting held on September 21, 2026
Neochem Bio Solutions Limited has informed the Exchange regarding Disclosure under Regulation 7(2) of SEBI (PIT) Regulations, 2015, for purchase of 1200 shares by Swapnil R. Makati, Managing Director of the Company
Disclosure under Regulation 7(2) of SEBI (PIT) Regulations, 2015, for purchase of 7200 shares by Swapnil R. Makati, Managing Director of the Company.
Change in Management regarding appointment of Mr. Siddharth Raj as Business Head - (Textiles) Corporate Accounts, Senior Management Personnel
About Dispatch Of Letter With Web-Link Of Annual Report For Financial Year 2025-26 to the Shareholders whose e-mail addresses are not registered with the Company.